These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7820990)

  • 1. [Clinical use of progestins].
    Brizzi C; Serrao L; Primiero FM
    Clin Ter; 1994 Oct; 145(10):325-30. PubMed ID: 7820990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estrogens and progestins in hormone replacement therapy in menopause].
    La Vecchia C
    Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, histopathological and therapeutic considerations in non-neoplastic abnormal uterine bleeding in menopause transition.
    Corniţescu FI; Tănase F; Simionescu C; Iliescu D
    Rom J Morphol Embryol; 2011; 52(3):759-65. PubMed ID: 21892516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestogen use in women approaching the menopause and breast cancer risk.
    Campagnoli C; Ambroggio S; Lotano MR; Peris C
    Maturitas; 2009 Apr; 62(4):338-42. PubMed ID: 19118958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical guide to prescribing estrogen replacement therapy.
    Corson SL
    Int J Fertil Menopausal Stud; 1995; 40(5):229-47. PubMed ID: 8556028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Shah NR
    Cancer; 2003 Oct; 98(7):1552-3; author reply 1553. PubMed ID: 14508845
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer in the older woman: diagnosis and prevention.
    Gambrell RD
    Geriatrics; 1988 Sep; 43(9):27-32, 35-6. PubMed ID: 3044928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rationale for a wider range of progestogens.
    Skouby SO
    Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and risk of breast cancer: the role of progestins.
    Stahlberg C; Pedersen AT; Lynge E; Ottesen B
    Acta Obstet Gynecol Scand; 2003 Apr; 82(4):335-44. PubMed ID: 12716318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL
    J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaginal bleeding patterns in women receiving hormone replacement therapy. Impact of various progestogen regimens.
    Thorneycroft IH; Gibbons WE
    J Reprod Med; 1999 Feb; 44(2 Suppl):209-14. PubMed ID: 11392034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone replacement therapy and cardiovascular risk].
    Maffei S; De Caterina R
    G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between premenopausal progestogen use and postmenopausal hormonal therapy in the GAZEL cohort.
    Ringa V; Fritel X; Varnoux N; Zins M; Piault S; Quelen C
    Maturitas; 2007 Nov; 58(3):216-25. PubMed ID: 17919857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hormone therapy on the endometrium.
    Deligdisch L
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soy phytoestrogens: an adjunct to hormone replacement therapy?
    Birge SJ
    Menopause; 2000; 7(4):209-12. PubMed ID: 10914612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.